Abstract: A mammal lacking expression of particular CD45 isoform in certain cells of the immune system is provided. The mammal may optionally contain a transgene encoding the CD45RO isoform. Also provided are methods of using these mammals.
Type:
Grant
Filed:
February 2, 1994
Date of Patent:
December 16, 2003
Assignee:
Ontario Cancer Institute, University Health Network